IndraLab

Statements

17alpha-ethynylestradiol inhibits MYD88. 1 / 1

| 1

reach

"Estrogen and progesterone appear to inhibit MyD88, thereby illustrating how clinical and tumor related factors - chemotherapy, MyD88, and estrogen and progesterone - might together plausibly give rise to interactions that modify clinical outcomes."

26780780

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

17alpha-ethynylestradiol inhibits MYD88. 1 / 1

INDRA sources:

Databases

Reading